- Home
- PTGX vs PFS Comparison
PTGX vs PFS Comparison
Compare PTGX & PFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | PFS |
|---|---|---|
| Founded | 2006 | 1839 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 2.4B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTGX | PFS |
|---|---|---|
| Price | $88.82 | $20.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $90.56 | $22.50 |
| AVG Volume (30 Days) | ★ 982.6K | 861.2K |
| Earning Date | 11-06-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 4.72% |
| EPS Growth | N/A | ★ 100.33 |
| EPS | 0.72 | ★ 1.96 |
| Revenue | $209,217,000.00 | ★ $836,917,000.00 |
| Revenue This Year | N/A | $26.36 |
| Revenue Next Year | $288.98 | $14.22 |
| P/E Ratio | $123.27 | ★ $10.38 |
| Revenue Growth | N/A | ★ 59.19 |
| 52 Week Low | $33.70 | $14.34 |
| 52 Week High | $96.54 | $21.29 |
Technical Indicators
Market Signals| Indicator | PTGX | PFS |
|---|---|---|
| Relative Strength Index (RSI) | 55.09 | 53.95 |
| Support Level | $84.11 | $20.57 |
| Resistance Level | $90.00 | $21.25 |
| Average True Range (ATR) | 3.27 | 0.40 |
| MACD | -0.65 | -0.08 |
| Stochastic Oscillator | 41.92 | 25.10 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About PFS Provident Financial Services Inc
Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.